Clinical psychologist and professor Monnica Williams is on a mission to bring psychedelics to therapists’ offices to help people heal from their racial traumas. To do this, she’s jumping over some big hurdles.
From July 1, authorised psychiatrists will be able to prescribe MDMA and psilocybin in some circumstances. Here’s what we’re excited and concerned about.
Australia is the first country in the world to legalise the medical use of psychedelics. But without a public subsidy, few Australians will be able to afford them.
Receiving a cancer diagnosis and undergoing cancer treatment can be a traumatizing experience. Psychedelics like LSD, psilocybin and MDMA could help alleviate symptoms from cancer-related PTSD.
From July this year, some psychiatrists will be able to prescribe psychedelics to some patients. Responses from experts working in the field are mixed.
Alberta’s new policy on psychedelic-assisted therapy for mental illness may set a precedent that moves Canadians one step closer to accepting psychedelics as medicinal substances.
British Columbia’s bold experiment provides an opportunity to implement more balance in Canadian drug policy, and a more principled withdrawal from the war on drugs.
The Drug and Substance Checking Bill currently moving through parliament marks another milestone in New Zealand’s shift away from criminalisation and towards harm reduction.
There’s buzz about MDMA – yes, the same ingredient in the street drug known as Ecstasy – being a game changer in the treatment of PTSD. A psychiatrist who treats PTSD says, “Not so fast.”
I was an expert witness to the coronial inquest into five drug-related deaths across Melbourne between July 2016 and January 2017. Here’s what we should do to prevent similar tragedies.
The TGA is currently evaluating a proposal to legalise MDMA and psilocybin for the treatment of mental illness. But there are a few reasons Australia isn’t quite ready to take this step.